Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology. Its product Grafalon is used in immunosuppressive therapies for the prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation, and in treatment of aplastic anemia.
|Employees (est.) (Sept 2021)||86||(+2%)|
When was Neovii founded?
Neovii was founded in 2003.
Who are Neovii key executives?
Neovii's key executives are Jürgen Pohle, Alfred Doucette and Christian Loss.
How many employees does Neovii have?
Neovii has 86 employees.
Who are Neovii competitors?
Competitors of Neovii include Reflexion Medical, Eutilex and Foghorn Therapeutics.
Where is Neovii headquarters?
Neovii headquarters is located at Zürcherstrasse 19, Rapperswil-Jona.
Where are Neovii offices?
Neovii has offices in Rapperswil-Jona, Lexington and Gräfelfing.
How many offices does Neovii have?
Neovii has 4 offices.
Receive alerts for 300+ data fields across thousands of companies